Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions
| Status: | Completed |
|---|---|
| Conditions: | Shingles, Shingles, Infectious Disease, Genital Herpes |
| Therapuetic Areas: | Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Other |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 1/25/2018 |
| Start Date: | September 2006 |
| End Date: | September 2006 |
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fed Conditions
The objective of this study was to prove the bioequivalence of Valacyclovir
Hydrochlorothiazide Caplet under fed conditions.
Hydrochlorothiazide Caplet under fed conditions.
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C.
- Treatment with known enzyme altering drugs.
- History of allergic or adverse response to valacyclovir hydrochloride or any
comparable or similar product.
We found this trial at
1
site
Click here to add this to my saved trials
